INI-4001

INI-4001 · Inimmune Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INI-4001, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Trial of INI-4001 in Patients With Advanced Solid Tumours [Phase 1]